New book by Larry Connors Click here Improve your trading - See how
Magellan Health Services, Inc. (Nasdaq:MGLN) today reported net income of $31.0 million, or $.88 per diluted common share, and segment profit of $64.5 million for the third quarter of 2009. The Company also increased guidance for the full year to the upper half of its previously disclosed range.
The Company attributed these results to strong revenue performance across all business segments and effective cost-of-care management. It also announced today that it has signed a binding letter of agreement with WellCare Health Plans, Inc. to expand management of behavioral health care for the plan's entire book of business, resulting in total annualized WellCare revenues in excess of $100 million.
Financial Results
For the quarter ended September 30, 2009, the Company reported net revenue of $667.6 million and net income of $31.0 million, or $.88 per diluted common share. For the prior year quarter, net revenue was $656.5 million and net income was $23.5 million or $.58 per diluted common share. Segment profit (which represents income from continuing operations before stock compensation expense, depreciation and amortization, interest expense, interest income, gain on sale of assets, special charges or benefits, and income taxes) for the current year quarter was $64.5 million, compared with $57.6 million in the prior year quarter. The Company ended the quarter with unrestricted cash and investments of $220.1 million, including the impact of stock repurchases as well as net cash used for the acquisition of First Health Services.
For the nine months ended September 30, 2009, the Company reported net revenue of $1.92 billion and net income of $62.9 million, or $1.77 per diluted common share. For the prior year period, the Company reported net revenue of $1.96 billion and net income of $62.6 million, or $1.55 per diluted common share. Segment profit for the first nine months of 2009 was $150.3 million versus $164.6 million for the prior year period.
See the attached tables detailing the Company's operating results, including results by segment.
Rene Lerer, M.D., chairman and chief executive officer, said, "Our financial performance in the third quarter was strong across all of our business segments, reflecting solid progress in maintaining and growing our customer relationships as well as our success in improving cost of care. By providing appropriate oversight and strong clinical care management, we have demonstrated success in achieving quality outcomes for our customers and their members while effectively controlling costs. This safeguarding of the quality and affordability of care is the foundation of our commitment. At the same time that we're focusing on these fundamentals, we're looking forward and investing in product development and innovation, expanding the depth and breadth of our service offerings and identifying new ways to deliver value to our customers."
Karen S. Rohan, president, said that the quarter's results demonstrated the progress and success of all businesses -- behavioral health, radiology (NIA), specialty pharmacy (ICORE), and Medicaid administration (First Health Services).
"Our strategic focus on customer retention and business diversification is yielding results across all of our lines of business," Rohan said. "This includes contributions from our newest business, First Health Services, which has further diversified and expanded the breadth of our service to Medicaid customers. In addition, we learned recently that our public sector behavioral health contract in Maricopa County has been extended for a fourth full year, through August 31, 2011. We are exceptionally pleased to have received this vote of confidence in our efforts and to have the opportunity to continue strengthening and transforming this system of care."
WellCare Expansion
The Company also announced today the signing of a binding letter of agreement with WellCare Health Plans to manage behavioral health services for all WellCare markets. This three-year contract expands upon the Company's current agreement with WellCare in the state of Georgia and will add approximately 900,000 Medicare and Medicaid beneficiaries and incremental annual revenue of $60 million. Pending regulatory approvals in each state, the Company expects all markets to be fully implemented by the end of the first quarter. The parties will enter into separate definitive agreements for each market to be served by the Company and the parties have agreed that implementation of such definitive agreements is contingent upon the approval of the definitive agreement for Florida business by the Medicaid agency in Florida. Total revenues from all regions, including Georgia, are projected to be approximately $100 million.
"As health care payors across the nation consider business solutions available to manage financial risk and provide high quality, affordable care to their customers and members, we have an emerging opportunity to introduce the services we can provide across all lines of business," Lerer said. "This trend is highlighted by discussions with organizations that historically have in-sourced management of behavioral health benefits for their membership and who are once again considering the value of a focused, strategic, value-added partner."
Outlook
Jonathan N. Rubin, the Company's chief financial officer, said that the strong financial results through September 30, 2009 have led the Company to increase guidance for the full year to the upper half of its previously disclosed range. This guidance, including estimates for First Health Services, projects full-year segment profit in the range of $207.5 million to $217.5 million and net income of $85.3 million to $95.5 million. This equates to diluted EPS of $2.41 to $2.70. The Company's EPS guidance reflects the impact of the repurchase of 431,000 shares through close of business yesterday, but excludes any impact from repurchases that may occur during the remainder of the fourth quarter.
Rubin noted, "Looking ahead to next year, we are in the process of developing business plans and will provide 2010 guidance in December. In the meantime, we currently expect segment profit growth in 2010, which reflects the recognition of a full year's revenues from First Health Services and newly contracted businesses, offset by projected membership declines within our commercial behavioral health and radiology customer base and continued margin compression as a result of economic pressures faced by health plan and public sector clients in particular."
Earnings Results Conference Call
Management will host a conference call at 10:30 a.m. Eastern time on Friday, October 30. To participate in the conference call, interested parties should call 1-888-566-8408 and reference the passcode Third Quarter Earnings approximately 15 minutes before the start of the call.
The conference call also will be available via a live Webcast at Magellan's investor relations page at www.MagellanHealth.com.
A taped replay of the conference call will be available for one week following the call. Interested parties should call 800-229-6227 or 402-220-9679 (from outside the U.S.) to listen.
Those who plan to access the call or Webcast are encouraged to read Magellan's Annual Report on Form 10-K for the year ended December 31, 2008, filed with the Securities and Exchange Commission on February 27, 2009, and subsequent Quarterly Reports on Form 10-Q, for material information regarding Magellan's operational and financial results, including the section entitled "Risk Factors."
About Magellan: Headquartered in Avon, Conn., Magellan Health Services, Inc. (Nasdaq:MGLN) is a leading specialty health care management organization. Its customers include health plans, corporations and government agencies.
Cautionary Statement: This release contains forward-looking statements within the meaning of the Securities Exchange Act of 1934 and the Securities Act of 1933, as amended, that involve a number of risks and uncertainties. All statements, other than statements of historical information provided herein, may be deemed to be forward-looking statements including, without limitation, statements regarding estimates of 2009 segment profit, net income, earnings per share, care trends, estimates of revenue and market implementation timing related to the WellCare letter of agreement, future share repurchases pursuant to the announced $100 million share repurchase, and directional guidance regarding segment profit for 2010. These statements are based on management's analysis, judgment, belief and expectation only as of the date hereof, and are subject to uncertainty and changes in circumstances. Without limiting the foregoing, the words "believes," "anticipates," "plans," "expects," "may," "should," "could," "estimate," "intend" and other similar expressions are intended to identify forward-looking statements. Actual results could differ materially due to, among other things, the possible election of certain of the Company's customers to manage the health care services of their members directly; changes in rates paid to and/or by the Company by customers and/or providers; higher utilization of health care services by the Company's risk members; delays, higher costs or inability to implement new business or other Company initiatives; the impact of changes in the contracting model for Medicaid contracts; termination or non-renewal of customer contracts; the impact of new or amended laws or regulations; governmental inquiries; litigation; competition; operational issues; health care reform; the impact of varying economic and market conditions on the Company's investment portfolio; the state of the national economy and adverse changes in economic conditions; and general business conditions. Additional factors that could cause actual results to differ materially from those reflected in the forward-looking statements include, but are not limited to, the risks discussed in the "Risk Factors" section included within the Company's most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date of this release. Segment profit information referred to herein may be considered a non-GAAP financial measure. Further information regarding this measure, including the reasons management considers this information useful to investors, is included in the Company's most recent Annual Report on Form 10-K and subsequent reports on Form 10-Q filed with the SEC.
MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
(In thousands, except per share amounts)
Three Months Ended September 30, Nine Months Ended September 30,
2008 2009 (1) 2008 2009 (1)
Net revenue $ 656,462 $ 667,589 $ 1,963,610 $ 1,922,905
Cost and expenses:
Cost of care 456,584 435,007 1,368,748 1,309,773
Cost of goods sold 44,281 50,139 134,518 151,497
Direct service costs and other operating expenses (2) 105,879 122,034 322,110 328,032
Depreciation and amortization 16,086 12,154 44,983 33,713
Interest expense 592 650 2,824 1,734
Interest income (4,127 ) (1,215 ) (13,336 ) (5,260 )
619,295 618,769 1,859,847 1,819,489
Income from continuing operations before income taxes 37,167 48,820 103,763 103,416
Provision for income taxes 13,678 17,833 41,142 40,470
Net income 23,489 30,987 62,621 62,946
Other comprehensive (loss) income (1,590 ) 52 (1,866 ) (168 )
Comprehensive income $ 21,899 $ 31,039 $ 60,755 $ 62,778
Weighted average number of common shares outstanding -- basic 40,272 35,128 39,991 35,426
Weighted average number of common shares outstanding -- diluted 40,722 35,331 40,457 35,566
Net income per common share -- basic $ 0.58 $ 0.88 $ 1.57 $ 1.78
Net income per common share -- diluted $ 0.58 $ 0.88 $ 1.55 $ 1.77
(1) For a more detailed discussion of Magellan's results for the
period ended September 30, 2009, refer to the Company's Quarterly
Report on
Form 10-Q which will be filed with the SEC on October 30, 2009, and
the live broadcast or taped replay of the Company's earnings
conference
call on October 30, 2009, which will be available at www.MagellanHealth.com.
(2) Includes stock compensation expense of $7,832 and $4,124 for the
three months ended September 30, 2008 and 2009, respectively, and
$26,349 and $16,724 for the nine months ended September 30, 2008 and
2009, respectively.
MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In thousands)
Nine Months Ended September 30,
2008 2009
Cash flows from operating activities:
Net income $ 62,621 $ 62,946
Adjustments to reconcile net income to net cash provided by
operating activities:
Depreciation and amortization 44,983 33,713
Non-cash interest expense 1,730 675
Non-cash stock compensation expense 26,349 16,724
Non-cash income tax expense 32,339 28,696
Cash flows from changes in assets and liabilities, net of effects
from
acquisitions of businesses:
Restricted cash 103,604 10,702
Accounts receivable, net (24,960 ) (7,139 )
Other assets (6,012 ) (22,945 )
Accounts payable and accrued liabilities 3,752 (18,466 )
Medical claims payable and other medical liabilities (7,571 ) (6,669 )
Other (68 ) 2,386
Net cash provided by operating activities 236,767 100,623
Cash flows from investing activities:
Capital expenditures (23,955 ) (25,808 )
Acquisitions and investments in businesses, net of cash acquired (425 ) (115,438 )
Purchase of investments (345,702 ) (213,377 )
Maturity of investments 92,992 247,631
Net cash used in investing activities (277,090 ) (106,992 )
Cash flows from financing activities:
Payments on long-term debt and capital lease obligations (12,686 ) (3 )
Payments to acquire treasury stock (13,523 ) (67,070 )
Proceeds from exercise of stock options and warrants 12,587 1,101
Tax benefit from exercise of stock options 5,443 2,980
Other (1,365 ) (259 )
Net cash used in financing activities (9,544 ) (63,251 )
Net decrease in cash and cash equivalents (49,867 ) (69,620 )
Cash and cash equivalents at beginning of period 312,372 211,825
Cash and cash equivalents at end of period $ 262,505 $ 142,205
MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
(In thousands, except membership amounts in millions)
Three Months Ended September 30, Nine Months Ended September 30,
2008 2009 2008 2009
Net revenue
- Commercial $ 163,240 $ 162,060 $ 486,792 $ 481,003
- Public Sector 363,798 336,327 1,084,808 1,001,368
- Radiology Benefits Management 72,692 78,279 223,890 222,403
- Specialty Pharmaceutical Management 56,732 65,111 168,120 192,319
- Medicaid Administration - 25,812 - 25,812
Total net revenue 656,462 667,589 1,963,610 1,922,905
Cost of care
- Commercial 85,867 86,031 252,569 264,668
- Public Sector 320,479 294,233 963,374 896,149
- Radiology Benefits Management 50,238 54,743 152,805 148,956
Total cost of care 456,584 435,007 1,368,748 1,309,773
Cost of goods sold - Specialty Pharmaceutical Management 44,281 50,139 134,518 151,497
Direct service costs and other operating expenses
- Commercial 38,018 37,843 113,588 114,376
- Public Sector 17,668 16,440 51,135 50,646
- Radiology Benefits Management 14,104 12,880 41,408 38,387
- Specialty Pharmaceutical Management 6,713 5,516 18,764 18,780
- Medicaid Administration - 22,138 - 22,138
- Corporate & Other 29,376 27,217 97,215 83,705
Total direct services costs and other operating expenses 105,879 122,034 322,110 328,032
Stock compensation expense (1)
- Commercial (424 ) (211 ) (1,097 ) (731 )
- Public Sector (231 ) (112 ) (598 ) (556 )
- Radiology Benefits Management (452 ) (152 ) (1,096 ) (946 )
- Specialty Pharmaceutical Management (2,325 ) (429 ) (6,445 ) (4,647 )
- Medicaid Administration - (358 ) - (358 )
- Corporate & Other (4,400 ) (2,862 ) (17,113 ) (9,486 )
Total stock compensation expense (7,832 ) (4,124 ) (26,349 ) (16,724 )
Segment profit (loss)
- Commercial 39,779 38,397 121,732 102,690
- Public Sector 25,882 25,766 70,897 55,129
- Radiology Benefits Management 8,802 10,808 30,773 36,006
- Specialty Pharmaceutical Management 8,063 9,885 21,283 26,689
- Medicaid Administration - 4,032 - 4,032
- Corporate & Other (24,976 ) (24,355 ) (80,102 ) (74,219 )
Total segment profit $ 57,550 $ 64,533 $ 164,583 $ 150,327
Reconciliation of segment profit to income from continuing
operations before income taxes:
Segment profit $ 57,550 $ 64,533 $ 164,583 $ 150,327
Stock compensation expense (7,832 ) (4,124 ) (26,349 ) (16,724 )
Depreciation and amortization (16,086 ) (12,154 ) (44,983 ) (33,713 )
Interest expense (592 ) (650 ) (2,824 ) (1,734 )
Interest income 4,127 1,215 13,336 5,260
Income from continuing operations before income taxes $ 37,167 $ 48,820 $ 103,763 $ 103,416
Membership
- Commercial 37.7
- Public Sector 1.8
- Radiology Benefits Management 17.7
Total membership 57.2
(1) Stock compensation expense is included in direct service costs and
other operating expenses; however, this
amount is excluded from the computation of segment profit since it
is managed on a consolidated basis.
SOURCE: Magellan Health Services, Inc.
Magellan Health Services, Inc. Investors: Renie Shapiro, 877-645-6464 or Media: Mike Fleming, 410-953-2408 / 602-790-9612 (cell)
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.